Menu

Distinct Regions Drive Responses to Anxiety, Fear

Researchers map brain activity associated with a person’s anticipation of or direct confrontation with danger.

Jan 1, 2018
Catherine Offord

ON EDGE: Researchers trained participants in two studies to associate visual cues with a mild electric shock to the finger. Following a visual cue suggesting a shock might be imminent—i.e., during threat anticipation—the volunteers’ brains showed higher activity in the bed nucleus of the stria terminalis (BNST), a region of the brain associated with defensive responses in uncertain situations. When participants were shocked—i.e., during threat confrontation—they showed higher activity in their amygdalae, two almond-shaped clusters of nuclei associated with fear and emotional stimulation.© EVAN OTO/SCIENCE SOURCE

EDITOR'S CHOICE IN NEUROSCIENCE

The paper
F. Klumpers et al., “How human amygdala and bed nucleus of the stria terminalis may drive distinct defensive responses,” J Neurosci, 37:9645-56, 2017.

When Floris Klumpers zapped people with electricity while working toward his PhD in the late 2000s, he expected his volunteers’ amygdalae—key emotion centers in the brain—to light up in anticipation of a shock. “There was this idea that the amygdala is the most important structure in emotion processing—especially in fear processing,” says Klumpers, then at Utrecht University in the Netherlands. “We were quite surprised, using fMRI studies, to not find amygdala activity when people were anticipating an adverse event.”

Klumpers assumed he’d made a mistake, but after replicating the finding in further experimental work, he began thinking about the different stages of animals’ fear responses. First, there’s anticipation, during which an individual becomes alert and plans reactions to possible danger. Then there’s confrontation, when it has to act to avoid imminent danger. Perhaps, Klumpers reasoned, the brain’s fear-processing regions treat these two phases differently.

To investigate, Klumpers, now a neuroscientist at Radboud University Medical Center, and colleagues recently collected data from more than 150 volunteers, who received mild electrical shocks to their fingers as they viewed a computer. “We have a simple cue on the screen that can predict the occurrence of an electrical stimulation,” Klumpers says. In one set of experiments, for example, a yellow square meant a shock was likely, while a blue square signaled no shock for the time being. Meanwhile, the researchers monitored participants’ heart rates and imaged their brains using fMRI.

Most people’s heart rates dropped on seeing the shock-predicting cue—a response “linked in previous studies to an enhanced state of alertness” and reaction planning, says Klumpers. Plus, neural activity increased in the bed nucleus of the stria terminalis, a tiny brain region associated with anxiety in rodents. Upon being shocked, though, heart rate accelerated—a response that “helps you mobilize resources” to react, Klumpers says—and neural activity shifted to regions associated with fear, including the amygdala.

The results indicate that threat anticipation and confrontation phases are separated in the brain, Klumpers notes, adding there’s substantial individual variation. For example, in people who reported childhood maltreatment on a questionnaire administered after the study, “we found that the amygdala was more active during threat anticipation,” he says. “The alarm system goes off a little bit earlier.

Caltech neuroscientist Dean Mobbs says that while the group’s main findings are plausible, he suspects a higher-resolution study would reveal finer-grained variation in activity within the regions studied. “I think it’s correct, but I don’t think it’s the full picture,” he says. He’d also prefer a more ecologically relevant stimulus than electricity, he adds; his group monitors people’s responses to a live tarantula.

Klumpers says he now wants to study people’s brains when they are planning how to avoid a threat. “In the real world, when we’re anticipating something we still have a window of opportunity to deal with it.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.